Dana Investment Advisors, Inc. Sage Therapeutics, Inc. Transaction History

Dana Investment Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$40.26 - $57.37 $571,893 - $814,940	-14,205 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$54.88 - $79.29 $166,451 - $240,486	3,033 Added 27.15%	14,205 $807,000
Q1 2021 May 13, 2021	BUY	$70.65 - $96.76 $789,301 - $1.08 Million	11,172 New	11,172 $836,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Dana Investment Advisors, Inc. with notifications on news.